Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New Treatment Strategy for Bone Metastases from Breast Cancer.

Kohno, Kitazawa, Konishi

    Breast Cancer (Tokyo, Japan)
    |November 25, 2000
    PubMed
    Summary

    This study shows that combining pamidronate with chemoendocrine therapy can improve bone metastasis in breast cancer patients. The treatment led to sclerotic changes in bone lesions and significant pain reduction in most patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    High prevalence of antibody to Toxoplasma gondii among humans in Surabaya, Indonesia.

    Japanese journal of infectious diseases·2001
    Same author

    IgM-class antibodies to TT virus (TTV) in patients with acute TTV infection.

    Hepatology research : the official journal of the Japan Society of Hepatology·2001
    Same author

    Plasmon-loss imaging of chains of crystalline-silicon nanospheres and silicon nanowires

    Journal of electron microscopy·2000
    Same author

    Scaling behaviors of branched polymers

    Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000
    Same author

    Spatiotemporal stability of one-way open coupled nonlinear systems

    Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000
    Same author

    A Case Report of Long-term Survival after Radiotherapy for a Solitary Brain Metastasis from Breast Cancer.

    Breast cancer (Tokyo, Japan)·2000

    Area of Science:

    • Oncology
    • Bone Metastasis Research
    • Pharmacology

    Background:

    • Breast cancer frequently metastasizes to bone, where tumor growth is facilitated by factors like parathyroid hormone-related protein.
    • Osteoclast-mediated bone resorption is a key process in bone metastasis, making it a target for therapeutic intervention.
    • Bisphosphonates are bone-targeting drugs known for their potent inhibition of osteoclastic activity.

    Purpose of the Study:

    • To evaluate the efficacy of chemoendocrine therapy combined with bisphosphonate (pamidronate) in breast cancer patients with bone metastasis.
    • To assess the impact of this combination therapy on osteolytic bone lesions and patient-reported pain.

    Main Methods:

    • A cohort of 53 breast cancer patients with bone metastasis received chemoendocrine therapy (primarily high-dose medroxyprogesterone acetate) plus pamidronate.

    Related Experiment Videos

  • The regimen was administered as a first-line treatment post-relapse for 27 patients and as a second or third-line treatment for 26 patients who failed prior therapies.
  • Treatment outcomes, including changes in osteolytic lesions and pain levels, were monitored over a median of 27 months.

    • Main Results:

    • Sclerotic changes, indicating bone healing, were observed in osteolytic lesions in 59% (31/53) of patients.
    • The observed effects on bone lesions did not correlate with disease-free interval, estrogen receptor status, prior treatments, or bone scan findings.
    • Significant pain reduction (83% of patients) was reported within 3 months of pamidronate administration.

    Conclusions:

    • The combination of pamidronate and chemoendocrine therapy demonstrates promising results for managing bone metastasis in breast cancer.
    • This therapeutic approach appears effective in promoting bone healing and alleviating pain associated with bone metastases.
    • Further investigation into this combined regimen is warranted for optimizing breast cancer bone metastasis treatment.